CarboDB Capsular polysaccharide 1495

From DrugPedia: A Wikipedia for Drug discovery

Revision as of 00:00, 15 January 2001 by Special:Contributions/ (Talk)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Contents

Carbohydrate Name

Capsular polysaccharide

Carbohydrate Class

Capsular polysaccharide

Source Microbe

Cryptococcus neoformans Serotype A [strain 24064]

Basic Structure

The major component of C. neoformans capsular polysaccharide is glucurunoxylomannan [GXM] consisting of an unbranched mannose backbone substituted with xylose, glucuronic acid and O-acetyl residues


Proposed functions

C. neoformans has a large polysaccharide capsule that is a determinant of virulence. The capsular polysaccharide causes immunologic paralysis and inhibits phagocytosis by macrophages. Soluble C. neoformans capsular polysaccharide enhances human immunodeficiency virus [HIV] infection in cultured cells, suggesting a new pathogenic role in AIDS

Antigenic Nature used to produce antibodies

Whole cells

Carrier Name

nil

Conjugation Method

nil

Antibodies

Polysera

Antibody type and class

IgM

Assay System

ELISA

Cross-reactivity

This antibody cross-reacted with Serotype D strains

Proposed epitopes

N/A

Proposed Utility

N/A

Weblink

PubMed

External Links